37 results
Page 2 of 2
424B3
xocycu7hl4 qyu1yj
1 Jul 21
Prospectus supplement
5:20pm
F-4/A
slr yf3465l
29 Jun 21
Registration of securities (foreign) (amended)
9:29am
F-4
9x24ig
15 Jun 21
Registration of securities (foreign)
12:00am
20-F
EX-2.7
dfzhr 4khekep
30 Apr 21
Annual report (foreign)
12:53pm
20-F
fml38
30 Apr 21
Annual report (foreign)
12:53pm
6-K
EX-99.1
6sdkstb6
20 Jan 21
Amryt Receives Reimbursement Approval from NICE for Myalepta® (metreleptin) in England and Wales
6:30am
424B4
ybk kq03ps
14 Jan 21
Prospectus supplement with pricing info
9:30am
F-1/A
3k3v8m is885rdx7k
12 Jan 21
Registration statement (foreign) (amended)
12:00am
F-1
sgc4ffyx
8 Jan 21
Registration statement (foreign)
4:58pm
DRS
cxz6k5xrz99 artwpr
18 Dec 20
Draft registration statement
12:00am
6-K
EX-99.1
efcja
3 Nov 20
Current report (foreign)
8:45am
6-K
EX-99.1
vgazl
9 Sep 20
Amryt Announces Positive Top Line Results from Pivotal Phase 3 “Ease” Trial of Filsuvez(r) In Epidermolysis Bullosa
8:23am
424B4
433f8a99k74 kaiw7
8 Jul 20
Prospectus supplement with pricing info
4:05pm
F-1/A
atgqddbzltx7wnwj7
6 Jul 20
Registration statement (foreign) (amended)
5:28pm
F-1
27y5y1smsqxeqo80c3vh
23 Jun 20
Registration statement (foreign)
5:21pm
DRS/A
cv5u993s
29 May 20
Draft registration statement (amended)
12:00am
DRS
g5fr4uqs sd369ldtbvk
19 Feb 20
Draft registration statement
12:00am